Janssen’s Spravato Enters US Market With Enhanced REMS And Plans For A Monotherapy Trial

 
• By Sue Sutter
  
Spravato manufacturing
Janssen is manufacturing Spravato in anticipation of a US roll-out starting in mid-March. • Source: Janssen
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews